articleAmerican Journal of Respiratory and Critical Care MedicineApr 29, 2022GREEN OA

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

GRGanesh RaghuMRMartine Remy-JardinLRLuca RicheldiCCCarey C. ThomsonYIYoshikazu Inoue
PubMed
Indexed incrossrefpubmed

Abstract

Abstract Background This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. Methods A committee was composed of multidisciplinary experts in ILD, methodologists, and patient representatives. 1) Update of IPF: Radiological and histopathological criteria for IPF were updated by consensus. Questions about transbronchial lung cryobiopsy, genomic classifier testing, antacid medication, and antireflux surgery were informed by systematic reviews and…

Citation impact

2,555
total citations
FWCI
344.19
Percentile
100%
References
176
Citations per year

Authors

41
  • GR
    Ganesh RaghuCorresponding
  • MR
    Martine Remy-Jardin
  • LR
    Luca Richeldi
  • CC
    Carey C. Thomson
  • YI
    Yoshikazu Inoue

Topics & keywords

Topics
Keywords
  • Guideline
  • Pirfenidone
  • Nintedanib
  • Idiopathic pulmonary fibrosis
  • Radiological weapon
  • Lung biopsy
  • Grading (engineering)
  • Interstitial lung disease
No related works found for this paper.

Funding